KANE JOHN CUA: Open Payments
NPI 1538562145 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 59 payments from 15 companies in 2025. Trend: 2023 $685 · 2024 $879 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $432 |
| GlaxoSmithKline, LLC. | 22 | $425 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $100 |
| Actelion Pharmaceuticals US, Inc. | 3 | $79 |
| GENZYME CORPORATION | 2 | $78 |
| Electromed, Inc. | 5 | $76 |
| Mallinckrodt Hospital Products Inc. | 2 | $70 |
| Lundbeck LLC | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $35 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, NUCALA, BREZTRI, REXULTI, DUPIXENT, SMARTVEST, ACTHAR.
Industry payments across CA — which companies pay providers there.
